Your browser doesn't support javascript.
loading
Managing alcohol withdrawal in the elderly.
Kraemer, K L; Conigliaro, J; Saitz, R.
Afiliación
  • Kraemer KL; Center for Research on Healthcare, Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania 15213, USA.
Drugs Aging ; 14(6): 409-25, 1999 Jun.
Article en En | MEDLINE | ID: mdl-10408740
The alcohol withdrawal syndrome is common in elderly individuals who are alcohol dependent and who decrease or stop their alcohol intake. While there have been few clinical studies to directly support or refute the hypothesis that withdrawal symptom severity, delirium and seizures increase with advancing age, several observational studies suggest that adverse functional and cognitive complications during alcohol withdrawal do occur more frequently in elderly patients. Most elderly patients with alcohol withdrawal symptoms should be considered for admission to an inpatient setting for supportive care and management. However, elderly patients with adequate social support and without significant withdrawal symptoms at presentation, comorbid illness or past history of complicated withdrawal may be suitable for outpatient management. Although over 100 drugs have been described for alcohol withdrawal treatment, there have been no studies assessing the efficacy of these drugs specifically in elderly patients. Studies in younger patients support benzodiazepines as the most efficacious therapy for reducing withdrawal symptoms and the incidence of delirium and seizure. While short-acting benzodiazepines, such as oxazepam and lorazepam, may be appropriate for elderly patients given the risk for excessive sedation from long-acting benzodiazepines, they may be less effective in preventing seizures and more prone to produce discontinuation symptoms if not tapered properly. To ensure appropriate benzodiazepine treatment, dose and frequency should be individualised with frequent monitoring, and based on validated alcohol withdrawal severity measures. Selected patients who have a history of severe or complicated withdrawal symptoms may benefit from a fixed schedule of benzodiazepine provided that medication is held for sedation. beta-Blockers, clonidine, carbamazepine and haloperidol may be used as adjunctive agents to treat symptoms not controlled by benzodiazepines. Lastly, the age of the patient should not deter clinicians from helping the patient achieve successful alcohol treatment and rehabilitation.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Abstinencia a Sustancias / Alcoholismo Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Aged / Humans Idioma: En Revista: Drugs Aging Asunto de la revista: GERIATRIA / TERAPIA POR MEDICAMENTOS Año: 1999 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Abstinencia a Sustancias / Alcoholismo Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Aged / Humans Idioma: En Revista: Drugs Aging Asunto de la revista: GERIATRIA / TERAPIA POR MEDICAMENTOS Año: 1999 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda